Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G O Klein

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
European Journal of Cancer & Clinical Oncology|February 1, 1982
Decreased sensitivity of immunoselected and NK-selected YAC lymphoma sublines to hybrid resistance in vivoG O Klein, A Grönberg, R Kiessling, et al.
The Tokai Journal of Experimental and Clinical Medicine|December 1, 1983
Genetic control of in vitro NK-activity and in vivo resistance to tumorsK Kärre, G O Klein, R Kiessling, et al.
Journal of Immunogenetics|October 1, 1980
The genetic regulation of NK-activity: studies on congenic mice with B10 or AKR backgroundG O Klein, K Kärre, G Klein, et al.
Immunogenetics|February 9, 2011
'Hybrid resistance' against parental tumors: One or several genetic patterns?G Klein, G O Klein, K Kärre, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1982
Hybrid resistance against a natural killer (NK) cell-resistant lymphoma (YWA) is mediated by a T cell-dependent mechanismA Grönberg, G O Klein, K Kärre, et al.
Nature|April 17, 1980
Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient miceK Kärre, G O Klein, R Kiessling, et al.
International Journal of Cancer|December 1, 1981
Incidence and type of tumors induced in C57BL bg/bg mice and +/bg littermates by oral administration of DMBAS Argov, A J Cochran, K Kärre, et al.
International Journal of Cancer|December 15, 1980
In vitro NK-activity and in vivo resistance to leukemia: studies of beige, beige//nude and wild-type hosts on C57BL backgroundK Kärre, G O Klein, R Kiessling, et al.
Clinical Immunology and Immunopathology|June 1, 1983
Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndromeF Merino, G O Klein, W Henle, et al.
International Journal of Cancer|August 15, 1983
Incidence and type of tumors induced by DMBA carcinogenesis in H-2 congenic strains on a B10 backgroundA Grönberg, A J Cochran, K Kärre, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Cancer & Clinical Oncology|February 1, 1982
Decreased sensitivity of immunoselected and NK-selected YAC lymphoma sublines to hybrid resistance in vivoG O Klein, A Grönberg, R Kiessling, et al.
The Tokai Journal of Experimental and Clinical Medicine|December 1, 1983
Genetic control of in vitro NK-activity and in vivo resistance to tumorsK Kärre, G O Klein, R Kiessling, et al.
Journal of Immunogenetics|October 1, 1980
The genetic regulation of NK-activity: studies on congenic mice with B10 or AKR backgroundG O Klein, K Kärre, G Klein, et al.
Immunogenetics|February 9, 2011
'Hybrid resistance' against parental tumors: One or several genetic patterns?G Klein, G O Klein, K Kärre, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1982
Hybrid resistance against a natural killer (NK) cell-resistant lymphoma (YWA) is mediated by a T cell-dependent mechanismA Grönberg, G O Klein, K Kärre, et al.
Nature|April 17, 1980
Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient miceK Kärre, G O Klein, R Kiessling, et al.
International Journal of Cancer|December 1, 1981
Incidence and type of tumors induced in C57BL bg/bg mice and +/bg littermates by oral administration of DMBAS Argov, A J Cochran, K Kärre, et al.
International Journal of Cancer|December 15, 1980
In vitro NK-activity and in vivo resistance to leukemia: studies of beige, beige//nude and wild-type hosts on C57BL backgroundK Kärre, G O Klein, R Kiessling, et al.
Clinical Immunology and Immunopathology|June 1, 1983
Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndromeF Merino, G O Klein, W Henle, et al.
International Journal of Cancer|August 15, 1983
Incidence and type of tumors induced by DMBA carcinogenesis in H-2 congenic strains on a B10 backgroundA Grönberg, A J Cochran, K Kärre, et al.
Pageof 3